mesoestetic strengthens and reinforces its commitment to innovation and development. The pharmaceutical laboratory specialising in cosmetic products and aesthetic medicine held an event in Viladecans last Monday in which it invited the media, organisations and various institutional authorities to present the expansion of its Viladecans plant.
This expansion has meant an investment of more than ten million euros for the company, which will allow the Catalan laboratory to triple its production capacity and improve the quality of its service to customers.
The amount invested will help the company to be more competitive, to join efforts in sustainability, to promote the digital transformation announced in 2022 and to improve the spaces and services for the more than 220 employees who are part of mesoestetic. mesoestetic detailed and explained in which area the total amount invested will be allocated. Two million euros will be used to implement the strategic digitalisation plan which will last for three years. Almost half a million euros have been earmarked for the new photovoltaic plant to make mesoestetic more sustainable. More than seven million euros are entirely to improve the company's production capacity to offer a better service to its customers and to grow in a healthy way. The remaining 450,000 euros have been invested in research, improvements and extensions to its laboratories.
During the opening ceremony, mesoestetic also reviewed its roadmap for the next five years. In these five years, innovation and research will be the driving forces of the company and will serve to increase synergies with a new electromedicine division. The digital transformation that mesoestetic is undergoing was also explained, consisting of a project that is already underway and which involves the implementation of a new ERP, the implementation of new CRM platforms, the design of a 360º cybersecurity strategy and the deployment of new business intelligence systems.
The company's president and founder, Joan Carles Font, took the floor and stressed that innovation and research continue to be intrinsic to the organisation's DNA. Representing the Generalitat de Catalunya was the Director General of Industry, Oriol Alcoba, who highlighted the growth of the group and argued that the commitment of the Catalan government authorities is to ensure the link between mesoestetic and Viladecans: "for our part we have to assume the responsibility of weaving an ecosystem around mesoestetic so that it is sufficiently attractive and competitive for the laboratory to be rooted here in Viladecans, in Catalonia, and to continue to be the preferred place for a company like this", argued Alcoba.
The company specialising in cosmetics and aesthetic medicine closed the 2022 financial year with a turnover of 63.5 million euros, an increase of 35% compared to 2021. mesoestetic closed 2022 with a net profit of 14.5 million euros. The Viladecans-based company expects to continue growing in 2023 and estimates that turnover this year will reach 74 million euros. mesoestetic is present in 109 countries and the international market accounts for 89% of its foreign turnover. At the presentation of results held at the beginning of the year, Carles Font explained that the group intends to open a new headquarters in Dubai.